Type of cancer | Type of nano-formulation | Size | Admintsation route | Result (s) | Ref |
---|---|---|---|---|---|
Breast cancer | Gelatin NPs | 200 | - | Inhibit HGF in MDA-MD-231 breast cancer cell line | [95] |
Prostate cancer | Chitosan NPs | 150–200 | - | Inhibit the tumor cell growth and proliferation | [88] |
Colon cancer | PLGA NPs | 127 | - | Increase in DNA damage levels of oxaliplatin | [97] |
Prostate cancer | PLA-PEG NPs | 260 | Intra-tumoral | Induction of apoptosis in prostate cancer PC3 cell line; inhibition of angiogenesis Significant decrease in tumor size in prostate cancer xenograft model | [89] |
Bladder cancer | Gold NPs | 20–1200 | Oral Intra-tumoral or intra-peritoneal | Reduction in tumor volume | [98] |
Neuroblastoma | Gold NPs | 25.55 | - | Induction of apoptosis | [93] |
Basal cell carcinoma | Liposomes | 157.4, 268.9 | Topic and intra-tumoral | Great amount of EGCG deposition in tumor tissues in BCC model in female nude mice | [99] |
Brast cancer | Chitosan-coated liposomes | 16.4 | - | Inhibit the tuomor cell proliferation and induce apoptosis in tumor cells | [87] |
Prostate cancer | Ca/Al-NO3 LDH | - | - | Improve anti-tumor activites | [100] |
Prostate cancer | Maltodextrin-gum arabic | 120 | Â | Improve anti-tumor activites | [101] |
Liver cancer | Ruthenium | 73.59 | - | Improve anti-tumor activites | [102] |